Association of asthma and lung cancer risk: A pool of cohort studies and Mendelian randomization analysis

Author:

Huang Qinyao12,Huang Yunxia12ORCID,Xu Senkai12,Yuan Xiaojun12,Liu Xinqi12,Chen Zisheng1

Affiliation:

1. Department of Respiratory and Critical Care Medicine, the Sixth Affiliated Hospital of Guangzhou Medical University, Qingyuan People’s Hospital, Qingyuan, China

2. The Sixth Clinical College, Guangzhou Medical University, Guangzhou, China.

Abstract

Background: Over the past 2 decades, population-based studies have shown an increased association between asthma and the risk of lung cancer. However, the causal links between these 2 conditions remain poorly understood. Methods: We conducted a comprehensive search of various databases, including PubMed, Embase, Web of Science, and Cochrane Library, up until May 04, 2023. Only articles published in English were included in our study. We performed a meta-analysis using random-effects models to calculate the odds ratio (OR) and corresponding 95% confidence interval (CI). Subgroup analyses were conducted based on study design, gender, and histologic types. We also conducted a 2-sample Mendelian randomization (MR) using the genome-wide association study pooled data (408,422 people) published by the UK Biobank to explore further the potential causal relationship between asthma and lung cancer. Results: Our meta-analysis reviewed 24 population-based cohort studies involving 1072,502 patients, revealing that asthma is significantly associated with an increased risk of lung cancer (OR = 1.29, 95% CI 1.19–1.38) in all individuals. Subgroup analysis showed a significantly higher risk of lung cancer in females with asthma (OR = 1.23, 95% CI 1.01–1.49). We found no significant association between asthma and lung adenocarcinoma (LUAD) (OR = 0.76, 95% CI 0.54–1.05), lung squamous carcinomas (LUSC) (OR = 1.09, 95% CI 0.79–1.50), or small-cell lung cancer (SCLC) (OR = 1.00, 95% CI 0.68–1.49). Interestingly, our MR analysis supported an increasing causality between asthma and lung cancer (OR = 1.11, 95% CI 1.04–1.17, P = .0008), specifically in those who ever smoker (OR = 1.09, 95% CI 1.01–1.16, P = .0173) and LUSC pathological type (OR = 1.15, 95% CI 1.05–1.26, P = .0038). Conclusion: Through meta-analysis, our study confirms that patients with asthma have a higher risk of developing lung cancer. Our MR study further support an increasing causal relationship between asthma and the risk of lung cancer, particularly in smokers and LUSC. Future studies examining the link between asthma and the risk of developing lung cancer should consider the bias of controlled and uncontrolled asthma.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine

Reference63 articles.

1. Asthma.;Papi;Lancet,2018

2. Cancer incidence in a general population of asthma patients.;González-Pérez;Pharmacoepidemiol Drug Saf,2006

3. Understanding the immunology of asthma: Pathophysiology, biomarkers, and treatments for asthma endotypes.;Gans;Paediatr Respir Rev,2020

4. Inflammation and lung cancer: roles of reactive oxygen/nitrogen species.;Azad;J Toxicol Environ Health Part B,2008

5. Histamine airway hyper-responsiveness and mortality from chronic obstructive pulmonary disease: a cohort study.;Hospers;Lancet,2000

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3